Please provide your email address to receive an email when new articles are posted on . Surveillance of patients carrying the CDKN2A gene mutation led to earlier detection of pancreatic ductal ...
Comprehensive targeted next-generation sequencing to reveal limited clonal evolution after concurrent chemoradiation in patients with squamous cell carcinoma of the head and neck. This is an ASCO ...
Pancreatic cancer surveillance in high-risk individuals may lead to detection of pancreatic ductal adenocarcinoma (PDAC) at an earlier stage and with improved survival. This study evaluated the yield ...
Cellular senescence contributes to IPF progression by promoting inflammation and disrupting immune homeostasis. Four key genes—CDKN2A, VEGFA, SOX2, and FOXO3—were identified as differentially ...
Telomir Pharmaceuticals (TELO) announced new preclinical cancer data showing that Telomir-1 reverses DNA methylation of CDKN2A, a master tumor suppressor gene silenced in many aggressive cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results